Geneesmiddelenbeleid

This motion concerns the national policy regarding the development, availability, and pricing of medicines. It aims to ensure that patients have reliable access to essential pharmaceutical treatments while managing the sustainability of the healthcare budget. This procedure primarily affects the healthcare sector, pharmaceutical companies, and patients who rely on government-funded medication.